VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $316,881 | -49.0% | 73,352 | -22.2% | 0.01% | -47.8% |
Q2 2023 | $621,332 | +86.4% | 94,284 | +92.0% | 0.02% | +64.3% |
Q1 2023 | $333,389 | -11.1% | 49,100 | -3.3% | 0.01% | -30.0% |
Q4 2022 | $375,139 | -25.6% | 50,763 | -0.5% | 0.02% | 0.0% |
Q3 2022 | $504,000 | -14.6% | 51,000 | -5.7% | 0.02% | -20.0% |
Q2 2022 | $590,000 | -25.4% | 54,100 | +7.4% | 0.02% | -50.0% |
Q4 2021 | $791,000 | +107.6% | 50,387 | +98.8% | 0.05% | +38.9% |
Q1 2021 | $381,000 | – | 25,342 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |